ACADIA HEALTHCARE CO INCACHC
ASignal's systematic analysis rates ACHC as Bearish.
Reflects the latest available analysis · analyzed Oct 16, 2026
The case on ACHC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- MACD histogram is expanding and above zero, indicating strengthening upward momentum
- Price is above SMA20 and SMA50, suggesting short-term uptrend
- Operating margin of 10.14% indicates some operational profitability
- Debt-to-equity ratio of 1.18x is manageable for the sector
- Current ratio of 1.57x suggests adequate short-term liquidity
- Negative free cash flow of $-104.96M raises sustainability concerns
- Net profit margin of -33.44% and negative ROE of -41.45% indicate severe profitability issues
- Revenue and earnings are declining YoY (-0.40%, -63.60% respectively)
- Reddit mentions are zero, indicating lack of retail investor interest
- Only one news source (Yahoo) available, limiting sentiment reliability
See the full verdict on ACHC
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ACHC
Most investors never get a second opinion, let alone several. ASignal runs ACHC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.